维普期刊资源整合服务平台（V6.5）

124篇 您的检索式：作者名="Defronzo R A"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Nephropathy in diabetes 显示文摘	Molitch M E DeFronzo R A Franz M J	2004	Diabetes Care2004，27，1：	2
2	Efficacy and tolerability of the DPP4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type-2 diabetes 显示文摘	DEFRONZO R A BURANT C F FLECK P	2012	J Clin Endocrinol Metab2012，97，5：	1
3	Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists pro- vide a rational therapeutic approach 显示文摘	Bays H L Mandarino R A DeFronzo	2004	J Clin Endocrinol Metab2004，89，2：	1
4	AMP-Activated Protein Kinase:Role in Metabolism and Therapeutic Implications显示文摘	Schimmack G Defronzo R A Musi N	2006	Diabetes Obes Metab2006，8，6：	1
5	Effects of exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metforrnin-treated patients with type 2 diabetes 显示文摘	DEFRONZO R A RATNER R E HAN J	2005	Diabetes Care2005，28，5：	1
6	Regulation of hepatic glucose metabolism in humans显示文摘	DeFronzo R A Ferrannini E		0，，02：	1
7	Glucose clamp technique:a method for quantifying insulin secretion and resistance显示文摘	DEFRONZO R A TOBIN J D ANDRES A R	1979	Am J Physiol1979，237，3：	1
8	The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with met- formin alone显示文摘	DeFronzo R A Hissa M N Garber A J	2009	Diabetes Care2009，32，9：	1
9	Effects of exenatide(exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes显示文摘	DeFronzo R A Ratner R E Han J	2005	Diabetes care2005，28，5：	1
10	Effect of in vivo vanadate treatment on insulin receptor tyrosine kinase activity in partially pancreatectomized diabetic rats显示文摘	CORDERA R ANDRAGHETTI G DEFRONZO R A	1990	Endocrinol1990，126，4：	1
11	Nephropathy in diabetic显示文摘	Molitch M E DeFronzo R A Franz M J	2004	Diabetes Care2004，27，1：	1
12	Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes显示文摘	DeFronzo R A Rather R E Hart J	2005	Diabetes Care2005，28，5：	1
13	AMP-activated protein kinase: Role in metabolism and therapeutic implications显示文摘	Schimmack G Defronzo R A Musi N	2006	Diabetes Obes Metab2006，8，：	1
14	The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man显示文摘	DEFRONZO R A COOKE C R ANDRES R	1975	J Clin Invest1975，55，2：	1
15	Metformin:a review of its metabolic effects显示文摘	CUSI K DEFRONZO R A	1998	Diabetes Rev1998，6，：	1
16	Glucose clamp technique:a method for quantifying insulin secretion and resist ance显示文摘	Defronzo R A Tobin J D Andres R	1979	Am J Physilo1979，237，3：	1
17	Effects of exenatide (ex- endin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes显示文摘	DeFronzo R A Ratner R E Han J	2005	Diabetes Care2005，28，5：	1
18	The insulin resistance syndrome: Physiological considerations 显示文摘	Kashyap S R Defronzo R A	2007	Diab Vasc Dis Res2007，4，1：	1
19	Pioglitazonefor diabetes prevention in impaired glucose tolerance 显示文摘	DeFronzo R A Tripathy D Schwenke D C*	2011	NewEngland Journal of Medicine2011，364，12：	1
20	Role of the adipocyte, free fatty acids, and ectopic fat in pathogcnesis of type 2 diabetes mellitus: Peroxisomal proliferatoractivated receptor agonists provide a rational therapeutic approach 显示文摘	BAYS H MANDARINO L DEFRONZO R A	2004	Clin Endocrinol Metab2004，89，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示